Title : Determination of susceptibility to fosfomycin and tigecycline of Enterobacteriaceae, particularly Escherichia coli isolates, producing extended-spectrum β-lactamases from multiple regional Canadian hospitals.

Pub. Date : 2013 Fall

PMID : 24421836






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Although limited in their indications, fosfomycin and tigecycline are potential agents to treat infections due to ESBL-producing organisms. Fosfomycin EsbL Escherichia coli
2 CONCLUSION: Although resistance to these antibiotics has previously been reported, the present study confirmed that isolates of ESBL-producing E coli from the Interior Health Region of British Columbia remain highly susceptible to both tigecycline and fosfomycin. Fosfomycin EsbL Escherichia coli